AngioGenex, Inc. Contracts & Agreements

8 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
AngioGenex, Inc. Convertible Promissory Note Agreement (2021)
Note Agreements
AngioGenex, Inc.
Pharmaceuticals
DE
2021
Modification Agreement to Development and Marketing Agreement between BioCheck, Inc. and AngioGenex, Inc.
Modification Agreements
AngioGenex, Inc.
Pharmaceuticals
2008
Genes-to-Leads Agreement between Cengent Therapeutics Inc. and AngioGenex for Lead Identification in Drug Discovery
Collaboration Agreements
AngioGenex, Inc.
Pharmaceuticals
CA
2006
Genes-to-Leads Agreement Between Cengent Therapeutics Inc. and AngioGenex for Lead Identification Services
Collaboration Agreements
AngioGenex, Inc.
Pharmaceuticals
CA
2006
Research Study Agreement between AngioGenex, Inc. and Biocheck (CRO) dated September 24, 2001
Services Agreements
AngioGenex, Inc.
Pharmaceuticals
CA
2006
Exclusive License Agreement between Sloan-Kettering Institute for Cancer Research and AngioGenex Inc.
License Agreements
AngioGenex, Inc.
Pharmaceuticals
2006
Agreement and Plan of Reorganization among eClic, Inc., eClic Acquisition, Inc., and AngioGenex, Inc.
Plan of Reorganization Agreements
AngioGenex, Inc.
Pharmaceuticals
NV
2005
Exclusive License Agreement between Memorial Sloan Kettering Cancer Center and AngioGenex, Inc. for Novel Compounds for Inhibition of Id
License Agreements
AngioGenex, Inc.
Pharmaceuticals
NY
2020